Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lopinavir 100mg / Ritonavir 25mg tablets
0503010G0AAADAD
|
Lopinavir/ritonavir | Lopinavir and ritonavir | Infections | No data available |
|
Lopinavir 133.3mg / Ritonavir 33.3mg capsules
0503010G0AAAAAA
|
Lopinavir/ritonavir | Lopinavir and ritonavir | Infections | No data available |
|
Lopinavir 200mg / Ritonavir 50mg tablets
0503010G0AAACAC
|
Lopinavir/ritonavir | Lopinavir and ritonavir | Infections | No data available |
|
Lopinavir 400mg/5ml / Ritonavir 100mg/5ml oral solution
0503010G0AAABAB
|
Lopinavir/ritonavir | Lopinavir and ritonavir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.